CN104928261B - 伪狂犬病病毒la‑a株、构建方法及其应用 - Google Patents
伪狂犬病病毒la‑a株、构建方法及其应用 Download PDFInfo
- Publication number
- CN104928261B CN104928261B CN201510388390.9A CN201510388390A CN104928261B CN 104928261 B CN104928261 B CN 104928261B CN 201510388390 A CN201510388390 A CN 201510388390A CN 104928261 B CN104928261 B CN 104928261B
- Authority
- CN
- China
- Prior art keywords
- plants
- pseudorabies virus
- virus
- ah02la
- prv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 title claims abstract description 144
- 238000010276 construction Methods 0.000 title claims abstract description 12
- 229960005486 vaccine Drugs 0.000 claims abstract description 62
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 53
- 238000004321 preservation Methods 0.000 claims abstract description 6
- 241000700605 Viruses Species 0.000 claims description 53
- 108020004414 DNA Proteins 0.000 claims description 39
- 239000012634 fragment Substances 0.000 claims description 23
- 238000011144 upstream manufacturing Methods 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 16
- 230000006801 homologous recombination Effects 0.000 claims description 15
- 238000002744 homologous recombination Methods 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 15
- 239000006228 supernatant Substances 0.000 claims description 15
- 229940031551 inactivated vaccine Drugs 0.000 claims description 14
- 230000003612 virological effect Effects 0.000 claims description 14
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 9
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 8
- 239000002609 medium Substances 0.000 claims description 6
- 239000002773 nucleotide Substances 0.000 claims description 6
- 125000003729 nucleotide group Chemical group 0.000 claims description 6
- 238000003780 insertion Methods 0.000 claims description 4
- 230000037431 insertion Effects 0.000 claims description 4
- 238000010257 thawing Methods 0.000 claims description 4
- 108091028026 C-DNA Proteins 0.000 claims description 2
- VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical compound O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 229960000380 propiolactone Drugs 0.000 claims description 2
- 208000010772 Dog disease Diseases 0.000 claims 1
- 108010047357 Luminescent Proteins Proteins 0.000 claims 1
- 102000006830 Luminescent Proteins Human genes 0.000 claims 1
- 239000005723 virus inoculator Substances 0.000 claims 1
- 231100000765 toxin Toxicity 0.000 abstract description 17
- 239000003053 toxin Substances 0.000 abstract description 17
- 241001465754 Metazoa Species 0.000 abstract description 14
- 239000003814 drug Substances 0.000 abstract description 3
- 230000002633 protecting effect Effects 0.000 abstract description 3
- 241000196324 Embryophyta Species 0.000 description 152
- 241000282898 Sus scrofa Species 0.000 description 53
- 231100000614 poison Toxicity 0.000 description 39
- 239000002574 poison Substances 0.000 description 39
- 210000004027 cell Anatomy 0.000 description 35
- 239000005090 green fluorescent protein Substances 0.000 description 29
- 238000011081 inoculation Methods 0.000 description 26
- 239000002585 base Substances 0.000 description 20
- 238000006243 chemical reaction Methods 0.000 description 16
- 238000012360 testing method Methods 0.000 description 15
- 208000015181 infectious disease Diseases 0.000 description 14
- 230000029087 digestion Effects 0.000 description 13
- 241000282887 Suidae Species 0.000 description 12
- 230000036760 body temperature Effects 0.000 description 12
- 201000010099 disease Diseases 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 11
- 239000013598 vector Substances 0.000 description 11
- 239000000047 product Substances 0.000 description 10
- 208000009305 pseudorabies Diseases 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 101150029683 gB gene Proteins 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 101150002378 gC gene Proteins 0.000 description 7
- 230000035772 mutation Effects 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 238000012163 sequencing technique Methods 0.000 description 7
- 238000012546 transfer Methods 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 241001249696 Senna alexandrina Species 0.000 description 6
- 238000000137 annealing Methods 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 101150036031 gD gene Proteins 0.000 description 6
- 108091008146 restriction endonucleases Proteins 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 238000010255 intramuscular injection Methods 0.000 description 5
- 239000007927 intramuscular injection Substances 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 102000003960 Ligases Human genes 0.000 description 4
- 108090000364 Ligases Proteins 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 101150072564 gE gene Proteins 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 108010042407 Endonucleases Proteins 0.000 description 3
- 102000004533 Endonucleases Human genes 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 108090000288 Glycoproteins Proteins 0.000 description 3
- 101710091977 Hydrophobin Proteins 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 108010052762 Suid herpesvirus 1 glycoprotein E Proteins 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000007850 degeneration Effects 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 230000009385 viral infection Effects 0.000 description 3
- VHTUHGNVVZPWGO-UHFFFAOYSA-N 7-(2-hydroxyethyl)-1,3-dimethyl-8-(pyridin-3-ylmethyl)purine-2,6-dione Chemical compound OCCN1C=2C(=O)N(C)C(=O)N(C)C=2N=C1CC1=CC=CN=C1 VHTUHGNVVZPWGO-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241001269238 Data Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- MURGITYSBWUQTI-UHFFFAOYSA-N fluorescin Chemical compound OC(=O)C1=CC=CC=C1C1C2=CC=C(O)C=C2OC2=CC(O)=CC=C21 MURGITYSBWUQTI-UHFFFAOYSA-N 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000000384 rearing effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 241001529453 unidentified herpesvirus Species 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 101000942941 Arabidopsis thaliana DNA ligase 6 Proteins 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- 101710197658 Capsid protein VP1 Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 238000012270 DNA recombination Methods 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 101150040913 DUT gene Proteins 0.000 description 1
- 238000009007 Diagnostic Kit Methods 0.000 description 1
- 101710204837 Envelope small membrane protein Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- 108091006027 G proteins Proteins 0.000 description 1
- 108091000058 GTP-Binding Proteins 0.000 description 1
- 241000701047 Gallid alphaherpesvirus 2 Species 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 101710145006 Lysis protein Proteins 0.000 description 1
- 108010090054 Membrane Glycoproteins Proteins 0.000 description 1
- 102000012750 Membrane Glycoproteins Human genes 0.000 description 1
- 101150098384 NEC2 gene Proteins 0.000 description 1
- 108091092724 Noncoding DNA Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000012807 PCR reagent Substances 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 206010067268 Post procedural infection Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 101150030723 RIR2 gene Proteins 0.000 description 1
- 101710118046 RNA-directed RNA polymerase Proteins 0.000 description 1
- 101150103019 SCP gene Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 241000725681 Swine influenza virus Species 0.000 description 1
- 101150110861 TRM2 gene Proteins 0.000 description 1
- 101150102071 TRX1 gene Proteins 0.000 description 1
- 101150105144 UL21 gene Proteins 0.000 description 1
- 101150003230 UL27 gene Proteins 0.000 description 1
- 101150023000 UL35 gene Proteins 0.000 description 1
- 101150085237 UL36 gene Proteins 0.000 description 1
- 101150100826 UL40 gene Proteins 0.000 description 1
- 101150044021 UL41 gene Proteins 0.000 description 1
- 101150104684 UL44 gene Proteins 0.000 description 1
- 101150117989 UL46 gene Proteins 0.000 description 1
- 101150063032 UL51 gene Proteins 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 101710108545 Viral protein 1 Proteins 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000004436 artificial bacterial chromosome Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- LXWYCLOUQZZDBD-LIYNQYRNSA-N csfv Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C1=CC=C(O)C=C1 LXWYCLOUQZZDBD-LIYNQYRNSA-N 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000011981 development test Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical class [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 201000002491 encephalomyelitis Diseases 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 101150055782 gH gene Proteins 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000000568 immunological adjuvant Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 238000004900 laundering Methods 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 238000011022 operating instruction Methods 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510388390.9A CN104928261B (zh) | 2015-07-03 | 2015-07-03 | 伪狂犬病病毒la‑a株、构建方法及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510388390.9A CN104928261B (zh) | 2015-07-03 | 2015-07-03 | 伪狂犬病病毒la‑a株、构建方法及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104928261A CN104928261A (zh) | 2015-09-23 |
CN104928261B true CN104928261B (zh) | 2017-10-31 |
Family
ID=54115688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510388390.9A Active CN104928261B (zh) | 2015-07-03 | 2015-07-03 | 伪狂犬病病毒la‑a株、构建方法及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104928261B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107828741B (zh) * | 2017-11-07 | 2021-01-12 | 江苏省农业科学院 | 伪狂犬病病毒双基因缺失弱毒株及其应用 |
CN109134669B (zh) * | 2018-09-19 | 2021-03-23 | 天康生物股份有限公司 | 猪伪狂犬病毒的融合蛋白及其制备方法、应用和疫苗 |
CN110387354B (zh) * | 2019-08-16 | 2022-11-08 | 江苏省农业科学院 | 伪狂犬病病毒传代致弱毒株及其应用 |
CN111117974B (zh) * | 2019-12-20 | 2022-02-22 | 华南农业大学 | 一种可视化绿色荧光猪伪狂犬病毒及其构建方法 |
CN117126818B (zh) * | 2023-10-25 | 2024-02-02 | 江西农业大学 | 利用ABE构建gE基因缺失PRV毒株的方法和应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103923884A (zh) * | 2014-02-21 | 2014-07-16 | 普莱柯生物工程股份有限公司 | 一种猪伪狂犬病病毒基因缺失株、疫苗组合物及其制备方法和应用 |
CN104069487A (zh) * | 2014-05-26 | 2014-10-01 | 上海创宏生物科技有限公司 | 一种动物用可鉴别灭活疫苗的制备方法 |
-
2015
- 2015-07-03 CN CN201510388390.9A patent/CN104928261B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103923884A (zh) * | 2014-02-21 | 2014-07-16 | 普莱柯生物工程股份有限公司 | 一种猪伪狂犬病病毒基因缺失株、疫苗组合物及其制备方法和应用 |
CN104069487A (zh) * | 2014-05-26 | 2014-10-01 | 上海创宏生物科技有限公司 | 一种动物用可鉴别灭活疫苗的制备方法 |
Non-Patent Citations (3)
Title |
---|
A novel gE-deleted pseudorabies virus (PRV) provides rapid andcomplete protection from lethal challenge with the PRV variantemerging in Bartha-K61-vaccinated swine population in China;Chun-Hua Wang等;《Vaccine》;20140430;第32卷(第27期);第3379-3385页 * |
A novel inactivated gE/gI deleted pseudorabies virus (PRV) vaccinecompletely protects pigs from an emerged variant PRV challenge;Zhenqing Gua等;《Virus Research》;20140918;第195卷;第57-63页 * |
猪伪狂犬病病毒SA株的分离鉴定及其gE基因缺失株转移载体的构建;管宇等;《中国畜牧兽医》;20071231;第34卷(第6期);第109-111页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104928261A (zh) | 2015-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10655146B2 (en) | Turkey herpesvirus vectored recombinant containing avian influenza genes | |
CN104364381B (zh) | 多价重组禽疱疹病毒和用于免疫禽类的疫苗 | |
CN104928261B (zh) | 伪狂犬病病毒la‑a株、构建方法及其应用 | |
CN105567648B (zh) | 用于免疫接种水禽物种的重组禽疱疹病毒载体和疫苗 | |
CN107815441B (zh) | 一种ⅱ型伪狂犬病毒减毒株及其制备方法和应用 | |
CN109439634B (zh) | 伪狂犬病病毒基因工程弱毒疫苗株及其应用 | |
CN102373180B (zh) | 表达禽流感病毒血凝素(ha)基因的重组鸭病毒性肠炎病毒疫苗株及其构建方法和应用 | |
JP3587065B2 (ja) | 鳥類感染型ヘルペス属ウイルスの組み換え体、およびこれを利用した組み換えワクチン | |
CN102618508A (zh) | 一种重组猪伪狂犬病毒及其构建方法和应用 | |
CN102533674B (zh) | 表达禽流感病毒血凝素基因的重组鸭病毒性肠炎病毒疫苗株及其构建方法和应用 | |
CN107384874A (zh) | 伪狂犬病毒流行株gI/gE基因缺失突变株及构建和应用 | |
CN109321534A (zh) | 一种重组基因viii型新城疫病毒弱毒株 | |
CN113308441B (zh) | 一株猫疱疹病毒i型病毒株及其应用 | |
CN109321535A (zh) | 一种热稳定的新城疫病毒弱毒疫苗候选株 | |
CN102559610B (zh) | 表达禽流感病毒血凝素基因的重组鸭病毒性肠炎病毒疫苗株及其构建方法和应用 | |
CN104059889A (zh) | 伪狂犬病病毒变异株双基因缺失毒株及其构建方法和应用 | |
CN105695423B (zh) | 表达传染性法氏囊病毒vp2基因的重组鸡马立克氏病病毒疫苗株及其构建方法和应用 | |
CN107828741B (zh) | 伪狂犬病病毒双基因缺失弱毒株及其应用 | |
CN113943714A (zh) | 一种猫杯状病毒毒株及其应用 | |
Han et al. | Efficacy of live virus vaccines against infectious laryngotracheitis assessed by polymerase chain reaction–restriction fragment length polymorphism | |
JPH0235079A (ja) | 感染性ウシ鼻気管炎ウイルスの挿入突然変異体 | |
CN110331135A (zh) | 表达基因vii型新城疫病毒融合蛋白的重组火鸡疱疹病毒候选疫苗株及制备方法 | |
CN114657154B (zh) | 一种羊传染性脓疱病毒减毒株的制备方法及其应用 | |
CN112891528B (zh) | 一种鸡传染性支气管炎疫苗株 | |
CN116064417A (zh) | 一株猫泛白细胞减少症病毒毒株及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20150923 Assignee: SHANGHAI SHEN LIAN BIOMEDICAL Corp. Assignor: JIANGSU ACADEMY OF AGRICULTURAL SCIENCES Contract record no.: X2023980048853 Denomination of invention: Pseudorabies virus LA-A strain, construction method and application Granted publication date: 20171031 License type: Common License Record date: 20231201 Application publication date: 20150923 Assignee: ZHEJIANG HISUN ANIMAL HEALTH PRODUCT Co.,Ltd. Assignor: JIANGSU ACADEMY OF AGRICULTURAL SCIENCES Contract record no.: X2023980048831 Denomination of invention: Pseudorabies virus LA-A strain, construction method and application Granted publication date: 20171031 License type: Common License Record date: 20231202 |
|
EE01 | Entry into force of recordation of patent licensing contract |